Clinical Trials Logo
  1. Home
  2. Patent Ductus Arteriosus
  3. NCT04415554
  4. Details
NCT04415554 Clinical Trial

Aminoglycosides and Duct

Patent Ductus Arteriosus Clinical Trial

Official title:
The Effect of Aminoglycosides on Ductus in Preterm Infants

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT04415554
Other study ID # CMC-19-0110-CTIL
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date July 2021
Est. completion date December 2022

Study information
Verified date February 2021
Source Carmel Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aim of the study is to assess the effect of aminoglycoside treatment on ductal closure in preterms

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 60
Est. completion date December 2022
Est. primary completion date July 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A to 3 Weeks
Eligibility Inclusion Criteria: infants born at or above 32 weeks of gestation - Exclusion Criteria: - infants who are unlikely to survive or have congenital heart defects

Study Design

Related Conditions & MeSH terms

Intervention

Diagnostic Test:
• echocardiography
echocardiography exam of the infant

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
Carmel Medical Center

Outcome
Type Measure Description Time frame Safety issue
Primary ductal closure closure of ductus arteriosus 3 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT04986839 - PAIR (Paracetamol and Ibuprofen Research) Pilot Trial Phase 2/Phase 3
Recruiting NCT03648437 - Paracetamol And Ibuprofen/Indomethacin in Closing Patent Ductus Arteriosus Phase 1
Completed NCT04126512 - Timing of Surgical PDA Ligation and Neonatal Outcomes
Not yet recruiting NCT06045130 - PUFAs in Preterm Infants
Completed NCT00217191 - Ibuprofen and Renal Function in Premature Infants Phase 4
Not yet recruiting NCT02894970 - A New Device for Measuring of Lung Photoplethysmography and Pulmonic Arterial Saturation N/A
Completed NCT02621528 - Lifetech CeraFlex™ Post-Market Surveillance Study N/A
Completed NCT03551600 - Splanchnic and Renal Tissue Oxygenation During Enteral Feedings in Neonates With Patent Ductus Arteriosus
Terminated NCT03982342 - Preliminary Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low-weight Infants N/A
Completed NCT01479218 - Safety and Effectiveness Study With a New PDA Occluder for Closure of Patent Ductus Arteriosus N/A
Completed NCT00795990 - Timing for the Medical Treatment of Patent Ductus Arteriosus in Preterm Infants N/A
Withdrawn NCT00554307 - Brain, Gut and Kidney Blood Flow During Medical Closure of PDA N/A
Terminated NCT00802685 - Timing of PDA Closure and Respiratory Outcome in Premature Infants N/A
Completed NCT03723889 - Patent Ductus Arteriosus and Splanchnic Oxygenation at First Feed
Recruiting NCT04397913 - Population Pharmacokinetics and Dosage Individualization of Paracetamol and Ibuprofen in Children With PDA
Completed NCT02750228 - PDA Post NICU Discharge
Recruiting NCT02220270 - Hyperion™ International Registry Trial N/A
Completed NCT01593163 - Echocardiographically Guided Versus Standard Ibuprofen Treatment for Patent Ductus Arteriosus Phase 3
Recruiting NCT06298344 - The Role of Thiamine After Transcatheter Closure in Children With Left-to-Right Shunt Congenital Heart Disease Early Phase 1
Completed NCT03277768 - Non-Invasive Detection of Tissue Oxygen Deprivation in Premature Infants With Patent Ductus Arteriosus.